Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Trial Identifier:	D419CC00026
Sponsor:	AstraZeneca
Start Date:	May 2023
Primary Completion Date:	December 2026
Study Completion Date:	December 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Fukui, Japan
Japan	Nara, Japan
Japan	Yamanashi, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.